Teleflex Strives for Zero Complications at the 2013 Society of Critical Care Medicine

  Teleflex Strives for Zero Complications at the 2013 Society of Critical Care

      Products and education designed to help providers strive for zero
                        complications in critical care

Business Wire

LIMERICK, Pa. -- January 16, 2013

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, will showcase anesthesia and vascular
products and educational programs that are designed to help healthcare
professionals in their goal towards achieving zero complications at the
Teleflex Booth 1001 during the Society of Critical Care Medicine, January
19-23, 2013 in San Juan, Puerto Rico.

Teleflex will highlight:

  *The Teleflex^® ISIS^® HVT^™, the first convertible endotracheal tube,
    which features an integrated suction port and separate suction line
    allowing for subglottic secretion suctioning on demand. Now clinicians can
    be free from the burden of choosing which tube is best for the patient at
    the time of intubation. When needed, a separate suction line can be
    attached to the ISIS HVT Endotracheal Tube via a secure locking
    connection. This versatile design allows for use of one endotracheal tube
    to meet the needs of patients requiring both short- and long-term
  *The LMA^® MADomizer^® ^ is a simple, effective delivery system for topical
    anesthetics, vasoconstrictors and other nasal or oral medications. The
    MADomizer design allows targeted delivery of exact drug doses to the nasal
    and oral mucosa. Its unique pump design and disposable tip also completely
    eliminate the risk of patient cross contamination that can occur with
    compressed air atomizers.^1 The LMA MADomizer is a single use device which
    allows for exact dosing, the clinician can choose medication or mix of
    medications, offers targeted delivery with a fine mist and has a bendable
  *ARROW^® VPS^®  is a central venous catheter tip location and navigation
    technology that allows real-time accurate confirmation of placement of
    peripherally inserted central catheters and central venous catheters. The
    ARROW^® VPS^® is indicated for use as an alternative method to fluoroscopy
    or chest X-ray for central venous catheter tip placement confirmation in
    adult patients when a steady “Blue Bullseye” is obtained. NOTE: If a
    steady “Blue Bullseye” is not obtained, standard hospital practice should
    be followed to confirm catheter tip location.
  *The ARROW^® ErgoPack^® System  is an ergonomic packaging system for
    vascular access procedures designed to efficiently facilitate compliance
    with best practices, evidence-based medicine, guidelines and
    recommendations from organizations to reduce the risk of Central
    Line-Associated Bloodstream Infections (CLABSI).
  *The ARROW^® PICC with Chlorag+ard^® technology provides complete intra-
    and extra-luminal protection from tip to hub by reducing bacterial and
    fungal colonization by 99.99% and reducing thrombus accumulation on
    catheter surfaces by 61% for at least 30 days.^2

In addition, Teleflex will offer:

  *In-booth Education for attendees at the Teleflex booth (#1001). Teleflex
    is proud to offer education in Airway Management/Respiratory Therapy and
    Vascular Access. The Airway Management/Respiratory Therapy education will
    focus on the prevention of Ventilator Associated Pneumonia (VAP); the
    Vascular Access education will focus on CVC insertion complications
    simulation, catheter malposition and prevention of arterial line
  *Hands-On Educational Opportunities at the Teleflex booth (#1001). SCCM
    Congress participants can practice CVC insertion on a computer simulator
    that is part of Teleflex’s Ultrasound-Guided CVC Insertion Course.

For more information on Teleflex’s anesthesia and vascular access products, as
well as its educational programs, visit

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range
of procedures in critical care and surgery. Our mission is to provide
solutions that enable healthcare providers to improve outcomes and enhance
patient and provider safety. Headquartered in Limerick, PA, Teleflex employs
approximately 11,100 people worldwide and serves healthcare providers in more
than 130 countries. Additional information about Teleflex can be obtained from
the company's website at

Forward-Looking Statements

Any statements contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any forward-looking
statements contained herein are based on our management's current beliefs and
expectations, but are subject to a number of risks, uncertainties and changes
in circumstances, which may cause actual results or company actions to differ
materially from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report on
Form 10-K.

Teleflex, Arrow, ErgoPack, Chlorag+ard, ISIS, HVT, LMA, MADomizer and VPS are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates. ©2013 Teleflex Incorporated. All rights reserved. 2012-1500


1.Wolfe, T., Are You Inadvertently Cross-Contaminating Patients in Your
    Practice?, Ear, Nose, and Throat Journal
2.Data on File, Teleflex Incorporated


Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
Press spacebar to pause and continue. Press esc to stop.